Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
ABBOTT VASCULAR INTERNATIONAL from Machelen (Brab.), company number BE0886537933, closed financial year 2025 with a result of € 337,289 after tax. For that financial year ABBOTT VASCULAR INTERNATIONAL recorded revenue of € 54.4 million and equity of € 21.5 million. Compared with financial year 2024, the result moved from € 750,074 to € 337,289. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 21.5 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 337,289
▼ 55% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 21.5 million.
People and assets in 2025
102.7
▲ 8.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 21.6 million
▼ 17% vs 2024
€ 210,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 22.2 million
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 251 days on average.
€ 9.6 million
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 47,737,704 | € 50,298,255 | € 54,908,674 | € 54,424,732 | ▼ 1% |
| Profit after taxes | € 2,456,047 | € 1,448,977 | € 750,074 | € 337,289 | ▼ 55% |
| Equity | € 18,989,573 | € 20,438,550 | € 21,188,623 | € 21,525,908 | ▲ 2% |
| Total debts | € 24,498,167 | € 27,257,506 | € 33,769,849 | € 31,830,943 | ▼ 6% |
| Retained profit | € 18,971,023 | € 20,420,000 | € 21,170,073 | € 21,507,358 | ▲ 2% |
| Balance sheet total | € 44,138,591 | € 48,346,907 | € 55,609,323 | € 54,007,702 | ▼ 3% |
| Employees (FTE) | 96.5 | 95.6 | 94.1 | 102.7 | ▲ 8.6 |
Key figures of ABBOTT VASCULAR INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ABBOTT VASCULAR INTERNATIONAL?
What happened at ABBOTT VASCULAR INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bradley Jay Slater stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 337,289 (▼ 55% vs 2024). Source: NBB ↗
- Maya Wakim became a director. NBB
- Bradley Jay Slater became a director. NBB
- Samih Al Mawass became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 2.5 million profit in 2022 to € 337,289 profit in 2025.
Paid € 3.5 million in corporate taxes since 2022.
Best year ever: 2022, with € 2.5 million profit.
A new publication or filing at ABBOTT VASCULAR INTERNATIONAL? We notify you, reason included.
Follow ABBOTT VASCULAR INTERNATIONALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ABBOTT VASCULAR INTERNATIONAL are Maya Wakim and Samih Al Mawass.
Directors
According to the 2025 annual accounts
Maya Wakim
Director
since 2026
Samih Al Mawass
Director
since 2021
Bradley Jay Slater
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Culliganlaan 2B
1831 Machelen (Brab.)
Culliganlaan 2 box B
1831 Machelen (Brab.)
Active since 1 February 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.537.933
- VAT number
- BE 0886.537.933
- Registered office
- Culliganlaan 2B, 1831 Machelen (Brab.)
- Names & denominations
- ABBOTT VASCULAR INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2007
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van hoofdkantoren